Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ART6043 |
| Synonyms | |
| Therapy Description |
ART6043 selectively inhibits DNA polymerase theta, which potentially induces apoptosis and decreases growth of tumor cells (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ART6043 | ART-6043|ART 6043 | ART6043 selectively inhibits DNA polymerase theta, which potentially induces apoptosis and decreases growth of tumor cells (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05898399 | Phase Ib/II | Olaparib ART6043 ART6043 + Olaparib | Study of ART6043 in Advanced/Metastatic Solid Tumors Patients | Active, not recruiting | USA | 0 |